216 related articles for article (PubMed ID: 10620501)
1. Inclusion of a furin-sensitive spacer enhances the cytotoxicity of ribotoxin restrictocin containing recombinant single-chain immunotoxins.
Goyal A; Batra JK
Biochem J; 2000 Jan; 345 Pt 2(Pt 2):247-54. PubMed ID: 10620501
[TBL] [Abstract][Full Text] [Related]
2. Construction, expression and characterization of chimaeric toxins containing the ribonucleolytic toxin restrictocin: intracellular mechanism of action.
Rathore D; Batra JK
Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):815-22. PubMed ID: 9210405
[TBL] [Abstract][Full Text] [Related]
3. Generation of active immunotoxins containing recombinant restrictocin.
Rathore D; Batra JK
Biochem Biophys Res Commun; 1996 May; 222(1):58-63. PubMed ID: 8630074
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of specific target recognition and RNA hydrolysis by ribonucleolytic toxin restrictocin.
Nayak SK; Bagga S; Gaur D; Nair DT; Salunke DM; Batra JK
Biochemistry; 2001 Aug; 40(31):9115-24. PubMed ID: 11478878
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic activity of ribonucleolytic toxin restrictocin-based chimeric toxins targeted to epidermal growth factor receptor.
Rathore D; Batra JK
FEBS Lett; 1997 May; 407(3):275-9. PubMed ID: 9175867
[TBL] [Abstract][Full Text] [Related]
6. Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studies.
Cao Y; Marks JD; Marks JW; Cheung LH; Kim S; Rosenblum MG
Cancer Res; 2009 Dec; 69(23):8987-95. PubMed ID: 19934334
[TBL] [Abstract][Full Text] [Related]
7. Localization of the catalytic activity in restrictocin molecule by deletion mutagenesis.
Nayak SK; Shveta ; Batra JK
Eur J Biochem; 2000 Mar; 267(6):1777-83. PubMed ID: 10712610
[TBL] [Abstract][Full Text] [Related]
8. Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains.
Newton DL; Xue Y; Olson KA; Fett JW; Rybak SM
Biochemistry; 1996 Jan; 35(2):545-53. PubMed ID: 8555226
[TBL] [Abstract][Full Text] [Related]
9. Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv).
Batra JK; Fitzgerald DJ; Chaudhary VK; Pastan I
Mol Cell Biol; 1991 Apr; 11(4):2200-5. PubMed ID: 2005905
[TBL] [Abstract][Full Text] [Related]
10. Antigen binding and cytotoxic properties of a recombinant immunotoxin incorporating the lytic peptide, melittin.
Dunn RD; Weston KM; Longhurst TJ; Lilley GG; Rivett DE; Hudson PJ; Raison RL
Immunotechnology; 1996 Sep; 2(3):229-40. PubMed ID: 9373315
[TBL] [Abstract][Full Text] [Related]
11. Role of individual cysteine residues and disulfide bonds in the structure and function of Aspergillus ribonucleolytic toxin restrictocin.
Nayak SK; Rathore D; Batra JK
Biochemistry; 1999 Aug; 38(31):10052-8. PubMed ID: 10433712
[TBL] [Abstract][Full Text] [Related]
12. The Aspergillus toxin restriction is a suitable cytotoxic agent for generation of immunoconjugates with monoclonal antibodies directed against human carcinoma cells.
Conde FP; Orlandi R; Canevari S; Mezzanzanica D; Ripamonti M; Muñoz SM; Jorge P; Colnaghi MI
Eur J Biochem; 1989 Jan; 178(3):795-802. PubMed ID: 2783572
[TBL] [Abstract][Full Text] [Related]
13. Role of cis prolines 112 and 126 in the functional activity of ribonucleolytic toxin restrictocin.
Goyal A; Seth D; Batra JK
Biochem Biophys Res Commun; 2002 Jul; 295(4):812-7. PubMed ID: 12127966
[TBL] [Abstract][Full Text] [Related]
14. Expression of ribonucleolytic toxin restrictocin in Escherichia coli: purification and characterization.
Rathore D; Nayak SK; Batra JK
FEBS Lett; 1996 Sep; 392(3):259-62. PubMed ID: 8774857
[TBL] [Abstract][Full Text] [Related]
15. Ribotoxin restrictocin manifests anti-HIV-1 activity through its specific ribonuclease activity.
Yadav SK; Batra JK
Int J Biol Macromol; 2015 May; 76():58-62. PubMed ID: 25709025
[TBL] [Abstract][Full Text] [Related]
16. A single amino acid substitution in ribonucleolytic toxin restrictocin abolishes its specific substrate recognition activity.
Nayak SK; Batra JK
Biochemistry; 1997 Nov; 36(44):13693-9. PubMed ID: 9354640
[TBL] [Abstract][Full Text] [Related]
17. Involvement of loops L2 and L4 of ribonucleolytic toxin restrictocin in its functional activity.
Dey P; Tripathi M; Batra JK
Protein Pept Lett; 2007; 14(2):125-9. PubMed ID: 17305598
[TBL] [Abstract][Full Text] [Related]
18. Designing the furin-cleavable linker in recombinant immunotoxins based on Pseudomonas exotoxin A.
Weldon JE; Skarzynski M; Therres JA; Ostovitz JR; Zhou H; Kreitman RJ; Pastan I
Bioconjug Chem; 2015 Jun; 26(6):1120-8. PubMed ID: 25997032
[TBL] [Abstract][Full Text] [Related]
19. Expression and characterization of recombinant human eosinophil-derived neurotoxin and eosinophil-derived neurotoxin-anti-transferrin receptor sFv.
Newton DL; Nicholls PJ; Rybak SM; Youle RJ
J Biol Chem; 1994 Oct; 269(43):26739-45. PubMed ID: 7929408
[TBL] [Abstract][Full Text] [Related]
20. Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas.
Crépin R; Goenaga AL; Jullienne B; Bougherara H; Legay C; Benihoud K; Marks JD; Poul MA
Cancer Res; 2010 Jul; 70(13):5497-506. PubMed ID: 20530676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
